EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery

Annalisa Buniello iD, Daniel Suveges, Carlos Cruz-Castillo, Manuel Bernal Llinares iD, Helena Cornu, Irene Lopez, Kirill Tsukanov, Juan María Roldán-Romero, Chintan Mehta, Luca Fumis, Graham McNeill, James D Hayhurst und 20 weitere

Nucleic Acids Research · 06.01.2025 · 53 (D1) · D1467-D1475

DOI: 10.1093/nar/gkae1128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 06.12.2024. Verfasst von Annalisa Buniello und 31 weiteren Autor:innen. Beteiligte Einrichtung: Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK. Hauptthemen laut MEDLINE: Drug Discovery. Die Arbeit wurde bisher 301-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Open Targets.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Open Targets Platform (https://platform.opentargets.org) is a unique, open-source, publicly-available knowledge base providing data and tooling for systematic drug target identification, annotation, and prioritisation. Since our last report, we have expanded the scope of the Platform through a number of significant enhancements and data updates, with the aim to enable our users to formulate more flexible and impactful therapeutic hypotheses. In this context, we have completely revamped our target–disease associations page with more interactive facets and built-in functionalities to empower users with additional control over their experience using the Platform, and added a new Target Prioritisation view. This enables users to prioritise targets based upon clinical precedence, tractability, doability and safety attributes. We have also implemented a direction of effect assessment for eight sources of target–disease association evidence, showing the effect of genetic variation on the function of a target is associated with risk or protection for a trait to inform on potential mechanisms of modulation suitable for disease treatment. These enhancements and the introduction of new back and front-end technologies to support them have increased the impact and usability of our resource within the drug discovery community.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryHumansSoftwareKnowledge BasesInternet

Autor:innen und Institutionen

  • Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.
  • European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.
  • AstraZeneca UK Limited.
  • Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.

ORCID-Profile: Annalisa Buniello, Manuel Bernal Llinares, Ian Dunham, Ellen M McDonagh, David Ochoa

Förderung

  • Wellcome Trust
  • Open Targets

Zitieren

APA

Buniello, A., Suveges, D., Cruz-Castillo, C., Llinares, M. B., Cornu, H., Lopez, I., Tsukanov, K., Roldán-Romero, J. M., Mehta, C., Fumis, L., McNeill, G., Hayhurst, J. D., Martinez Osorio, R. E., Barkhordari, E., Ferrer, J., Carmona, M., Uniyal, P., Falaguera, M. J., Rusina, P., …, & Ochoa, D. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research, 53(D1), D1467-D1475. https://doi.org/10.1093/nar/gkae1128

Vancouver

Buniello A, Suveges D, Cruz-Castillo C, Llinares MB, Cornu H, Lopez I, et al. Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research. 2025;53(D1):D1467-D1475. doi:10.1093/nar/gkae1128

BibTeX
@article{Buniello2025,
  author = {Buniello, Annalisa and Suveges, Daniel and Cruz-Castillo, Carlos and Llinares, Manuel Bernal and Cornu, Helena and Lopez, Irene and Tsukanov, Kirill and Roldán-Romero, Juan María and Mehta, Chintan and Fumis, Luca and McNeill, Graham and Hayhurst, James D and Martinez Osorio, Ricardo Esteban and Barkhordari, Ehsan and Ferrer, Javier and Carmona, Miguel and Uniyal, Prashant and Falaguera, Maria J and Rusina, Polina and Smit, Ines and Schwartzentruber, Jeremy and Alegbe, Tobi and Ho, Vivien W and Considine, Daniel and Ge, Xiangyu and Szyszkowski, Szymon and Tsepilov, Yakov and Ghoussaini, Maya and Dunham, Ian and Hulcoop, David G and McDonagh, Ellen M and Ochoa, David},
  title = {Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery},
  journal = {Nucleic Acids Research},
  year = {2025},
  volume = {53},
  number = {D1},
  pages = {D1467--D1475},
  doi = {10.1093/nar/gkae1128}
}
Kostenlos starten →